A detailed history of Parallel Advisors, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 125 shares of FLGT stock, worth $2,516. This represents 0.0% of its overall portfolio holdings.

Number of Shares
125
Previous 125 -0.0%
Holding current value
$2,516
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$19.09 - $22.57 $1,298 - $1,534
-68 Reduced 35.23%
125 $2,000
Q1 2024

May 06, 2024

BUY
$21.55 - $29.29 $991 - $1,347
46 Added 31.29%
193 $4,000
Q4 2023

Feb 09, 2024

BUY
$23.64 - $30.27 $614 - $787
26 Added 21.49%
147 $4,000
Q3 2023

May 20, 2024

SELL
$26.74 - $40.81 $2,914 - $4,448
-109 Reduced 47.39%
121 $3,000
Q3 2023

Nov 13, 2023

SELL
$26.74 - $40.81 $2,914 - $4,448
-109 Reduced 47.39%
121 $3,000
Q2 2023

May 20, 2024

SELL
$28.52 - $40.7 $28 - $40
-1 Reduced 0.43%
230 $8,000
Q2 2023

Aug 04, 2023

SELL
$28.52 - $40.7 $28 - $40
-1 Reduced 0.43%
230 $8,000
Q1 2023

May 20, 2024

BUY
$29.39 - $36.27 $1,116 - $1,378
38 Added 19.69%
231 $7,000
Q1 2023

Apr 25, 2023

BUY
$29.39 - $36.27 $176 - $217
6 Added 2.67%
231 $7,000
Q4 2022

Feb 03, 2023

SELL
$29.23 - $40.28 $233 - $322
-8 Reduced 3.43%
225 $6,000
Q3 2022

Nov 10, 2022

SELL
$37.92 - $63.74 $720 - $1,211
-19 Reduced 7.54%
233 $9,000
Q2 2022

Aug 01, 2022

SELL
$47.98 - $62.75 $3,358 - $4,392
-70 Reduced 21.74%
252 $14,000
Q1 2022

Apr 28, 2022

SELL
$49.85 - $96.11 $16,899 - $32,581
-339 Reduced 51.29%
322 $20,000
Q4 2021

Jan 20, 2022

SELL
$77.3 - $105.0 $8,657 - $11,760
-112 Reduced 14.49%
661 $66,000
Q3 2021

Nov 02, 2021

SELL
$74.87 - $110.87 $7,487 - $11,087
-100 Reduced 11.45%
773 $70,000
Q2 2021

Aug 06, 2021

SELL
$66.8 - $100.45 $26,118 - $39,275
-391 Reduced 30.93%
873 $81,000
Q1 2021

Apr 23, 2021

BUY
$59.3 - $183.85 $74,955 - $232,386
1,264 New
1,264 $122,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.